Henry Schein Inc stock (US8064071025): Dental and medical distributor reports Q1 results and raises outlook

Henry Schein Inc reports first?quarter earnings with modest revenue growth and an improved full?year outlook, reinforcing its position in the dental and medical supply market.

Henry Schein Inc reported first?quarter 2026 results that showed modest revenue growth and an improved full?year outlook, sending its stock higher in early trading on Nasdaq. The company cited steady demand for dental and medical products, along with disciplined cost management, as key drivers of its performance, according to Henry Schein investor relations as of 05/08/2026.

For the quarter ended March 31, 2026, Henry Schein posted revenue of about 3.1 billion USD, up roughly 3% year?over?year, with dental?related sales accounting for the majority of the total. Adjusted earnings per share came in at 1.15 USD, above the prior?year quarter and slightly ahead of consensus estimates, reflecting lower operating expenses and favorable product mix, according to Henry Schein earnings release as of 05/08/2026.

As of: 08.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Henry Schein Inc
• Sector/industry: Healthcare distribution, dental and medical supplies
• Headquarters/country: Melville, New York, United States
• Core markets: United States, Canada, Europe, and select international markets
• Key revenue drivers: Dental consumables and equipment, medical supplies, technology and software solutions
• Home exchange/listing venue: Nasdaq (ticker: HSIC)
• Trading currency: USD

Henry Schein Inc: core business model

Henry Schein Inc operates as a leading distributor of dental and medical products, equipment, and technology solutions to practitioners and institutions across North America and Europe. The company serves dentists, dental laboratories, physicians, and other healthcare providers by offering a broad catalog of consumables, instruments, imaging systems, and practice?management software, according to Henry Schein corporate profile as of 05/08/2026.

Its business model centers on high?volume, low?margin distribution of recurring?use items such as dental materials, personal protective equipment, and medical disposables, complemented by higher?margin equipment and technology sales. By bundling products, logistics, and digital tools, Henry Schein aims to deepen relationships with customers and increase wallet share over time, according to Henry Schein business overview as of 05/08/2026.

Main revenue and product drivers for Henry Schein Inc

Dental consumables and equipment represent the largest revenue segment for Henry Schein, driven by routine patient visits, preventive care, and ongoing practice investments in modernization. The company supplies everything from basic handpieces and burs to advanced imaging systems and CAD/CAM solutions, which benefit from long?term trends toward digital dentistry and practice efficiency, according to Henry Schein product portfolio as of 05/08/2026.

On the medical side, Henry Schein distributes supplies and equipment to physician offices, surgery centers, and long?term care facilities, including infection?control products, diagnostic devices, and point?of?care technologies. This segment has gained importance as outpatient care settings expand and providers seek integrated supply?chain partners, according to Henry Schein medical business description as of 05/08/2026.

Why Henry Schein Inc matters for US investors

For US investors, Henry Schein offers exposure to the resilient dental and outpatient medical supply chain, which tends to be less cyclical than broader healthcare capital spending. The company’s Nasdaq listing and predominantly US?dollar?denominated revenues make it accessible to domestic retail portfolios, while its diversified customer base across thousands of small?practice owners helps mitigate concentration risk, according to Henry Schein investor presentation as of 05/08/2026.

At the same time, Henry Schein’s performance is closely tied to macroeconomic factors such as interest rates, inflation in healthcare inputs, and elective?procedure volumes, which can influence practitioner spending on equipment and technology. Investors often watch the company’s quarterly commentary for signals on practice utilization and capital?expenditure sentiment in the dental and medical sectors, according to Henry Schein earnings commentary as of 05/08/2026.

Conclusion

Henry Schein Inc’s latest quarterly results highlight steady growth in dental and medical distribution, supported by recurring demand for consumables and a gradual recovery in equipment spending. The company’s raised full?year outlook suggests confidence in underlying practice activity and its ability to manage costs in a competitive environment, according to Henry Schein earnings release as of 05/08/2026.

However, investors should remain mindful of margin pressures from pricing dynamics, supply?chain costs, and potential shifts in elective?care volumes. Henry Schein’s long?term trajectory will depend on its success in expanding technology and software offerings, integrating acquisitions, and maintaining strong relationships with independent practitioners, according to Henry Schein investor materials as of 05/08/2026.

This article does not constitute investment advice. Stocks are volatile financial instruments.